Guangzhou Kingmed Diagnostics Group: Shareholder reduces holdings by about 180,000 shares

NBD AI Bulletin -- Guangzhou Kingmed Diagnostics Group Co., Ltd (SH 603882, close price: 127.07 yuan) on March 5 announced that the Company was notified by its shareholder Guochuang Kaiyuan Equity Investment Management that the latter offloaded about 180,000 shares at the price of 156.26 yuan~166.38 yuan each via centralized bidding from December 8, 2020 to March 5, 2021 and the shares account for 0.04% of the Company's total equity. The term of the reduction plan has been halfway through.

The 2019 annual report shows that Guangzhou Kingmed Diagnostics Group mainly engages in third-party medical diagnosis, accounting for 94.22% of its revenue.

Guangzhou Kingmed Diagnostics Group's general manager and chairman is Liang Yaoming, male, 57 years old, Chinese national, no overseas permanent residency, MBA.

(By Gao Han)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.